Antinuclear autoantibodies in patients with inflammatory bowel disease: High prevalence in first-degree relatives

Digestive Diseases and Sciences

Volumn 42, Issue 8, 1997, Pages 1593-1597

  Folwaczny, C ^a   Noehl, N ^a   Endres, S P ^a   Heldwein, W ^a   Loeschke, K ^a   Fricke, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antinuclear autoantibodies; Crohn's disease; First degree relatives; Ulcerative colitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; FLUORESCEIN ISOTHIOCYANATE; HEAT SHOCK PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CROHN DISEASE; ENTERITIS; FAMILIAL DISEASE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED;

EID: 0030881823     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018832608899     Document Type: Article

References (38)

1. Zauli D, Crespi C, Dall' Amore P, Bianchi FB, Pisi E: Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 32:140-144, 1985
2. Hibi T, Ohara M, Toda K, Hara A, Ogata H, Iwao Y, Watanabe N, Watanabe M, Hamada Y, Kobayashi K: In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut 31:1371-1376, 1990
3. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210, 1990
4. Seibold F, Weber P, Jenss H, Wiedmann KH: Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: Specific markers for a subgroup of patients with Crohn's disease. Gut 32:1192-1197, 1991
5. Stocker W, Otte M, Scriba PC: Immunopathogenesis of Crohn's disease. Dtsch Med Wochenschr 109:1984-1986, 1984
6. Podolsky DK: Inflammatory bowel disease (2). N Engl J Med 325:1008-1016, 1992
7. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 100:1590-1596, 1991
8. Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM: Soluble interleukin-2 receptors, antineutrophil cytoplasmatic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34:658-664, 1993
9. Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S: Distinct production of autoantibodies to nuclear components in ulcerative colitis and Crohn's disease. Clin Immunol Immunopathol 77:349-357, 1995
10. Farmer RG: Association of inflammatory bowel disease in families. Front Gastrointest Res 11:235-241, 1986
11. Fiocchi C, Roche JK, Michener WM: High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 110:786-794, 1989
12. Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206-1211, 1995
13. Mohan C, Datta SK: Lupus: Key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77:209-220, 1995
14. Godeau P, Piette JC, Frances C, Huong Du LT, Bletry O, Wechsler B: The multiple clinical aspects of lupus. Clin Exp Rheumatol, Suppl 5:27-35, 1990
15. Brey RL: Antiphospholipid antibodies and stroke. Heart Dis Stroke 1:379-382, 1992
16. Cameron JS, Frampton G: The antiphospholipid syndrome and the lupus anticoagulant. Pediatr Nephrol 4:663-678, 1990
17. Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245-251, 1975
18. Vecchi M, Cattaneo M, de Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 21:165-170, 1991
19. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 3:773-778, 1992
20. Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, Hudson M, Sawyerr AM, Pounder RE: Early mucosal changes in Crohn's disease. Gut 34:375-381, 1993
21. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2(8671):1057-1062, 1989
22. Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 108:1011-1015, 1995
23. Bennet RA, Rubin PH, Present DH: Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 100:1638-1643, 1991
24. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990-996, 1988
25. Colombel JF, Grandbastien B, Gower-Russeau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Belaiche J, Hostein J, Hugot JP, Van Kruiningen H, Cortot A: Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111:604-607, 1996
26. Bayless TM, Tokayer AZ, Polito JM, Quaskey SA, Mellits ED, Harris LM: Crohn's disease: Concordance for site and clinical type in affected family members-potential hereditary influences. Gastroenterology 111:573-579, 1996
27. Polito MJ, Rees CR, Childs B, Mendeloff AI, Harris LM, Bayless TM: Preliminary evidence for genetic anticipation in Crohn's disease. Lancet 347:798-800, 1996
28. Polito JM, Childs B, Mellits DE, Tokayer AZ, Harris LM, Bayless TM: Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111:580-586, 1996
29. Peeters M, Nevens H, Baert F, Hiele M, De Meyer AM, Vlietinck R, Ruutgerts P: Familial aggregation in Crohn's disease: Increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111:597-603, 1996
30. Satsangi J, Grootscholten C, Holt H, Jewell DP: Clinical patterns of familial inflammatory bowel disease. Gut 38:738-741, 1996
31. Calkins BM, Mendeloff AI: Epidemiology of inflammatory bowel disease. Epidemiol Rev 8:60-91, 1986
32. Shanahan F, Duerr HR, Rotter IJ, Yang H, Sutherland RL, McElree C, Landers JC, Targan SR: Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity. Gastroenterology 103:456-461, 1992
33. Seibold F, Slametschka D, Gregor M, Weber P: Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107:532-536, 1994
34. Reumaux D, Delecourt L, Colombel JF, Noel LH, Duthilleul P, Cortot A: Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. Gastroenterology 103:1706, 1992 (letter; comment)
35. Monteleone G, Doldo P, Marasco R, Parello T, Imeneo M, DeMedici A, Giglio A, Luzza F, Pallone F: Perinuclear neutrophil autoantibodies (p-ANCA) in unaffected relatives of patients with ulcerative colitis (UC). Suggestions against familial aggregation. Gut 35(suppl 4):A31, 1994
36. Lee JC, Lennard-Jones JE, Cambridge G: Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 108:428-433, 1995
37. Papo M, Quer JC, Pastor MR, Garcia-Pardo G, Prats E, Mirapeix E, Rodriguez R, Richart C: Antineutrophil cytoplasmatic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 91:1512-1515, 1996
38. Folwaczny C, Noehl N, Endres SP, Heldwein W, Loeschke K, Fricke H: Anti-goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology (in press)